Radzi Chinyanganya
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- The UK faces risks of AI power deficit due to reliance on foreign technology, prompting calls for government support to develop domestic computing capabilities and reduce dependency.
- UK rents reach new highs as supply struggles to meet demand, prompting calls for policy action to address the rental affordability crisis.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a platform for delivering RNA therapeutics to muscle tissue.
- The UK faces risks of AI power deficit due to reliance on foreign technology, prompting calls for government support to develop domestic computing capabilities and reduce dependency.
- UK rents reach new highs as supply struggles to meet demand, prompting calls for policy action to address the rental affordability crisis.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Radzi Chinyanganya
News from Radzi Chinyanganya
